Bevatas Benefits & Uses

Bevatas is used to treat the following -

Other Benefits

Colon Cancer
Rectal Cancer
Non-Small Cell Lung Cancer
Kidney Cancer

Bevatas Dosage & How to Take

This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.

Find the right dosage based on disease and age

Age Group	Dosage
Adult	Disease: Kidney Cancer Before or After Meal: As advised by a physician Single Maximum Dose: 10 mg/kg Dosage Route: Parenteral Frequency: 2 Weekly Course Duration: As directed by the doctor Special Instructions: As prescribed by the doctor
Adult(Female)	Disease: Ovarian Cancer Before or After Meal: As advised by a physician Single Maximum Dose: 10 mg/kg Dosage Route: Parenteral Frequency: 2 Weekly Course Duration: As directed by the doctor Special Instructions: As prescribed by the doctor
Geriatric	Disease: Kidney Cancer Before or After Meal: As advised by a physician Single Maximum Dose: 10 mg/kg Dosage Route: Parenteral Frequency: 2 Weekly Course Duration: As directed by the doctor Special Instructions: As prescribed by the doctor

Bevatas Related Warnings

Is the use of Bevatas safe for pregnant women?

Bevatas can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.

Severe
Is the use of Bevatas safe during breastfeeding?

Bevatas should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.

Severe
What is the effect of Bevatas on the Kidneys?

Kidney can be affected by Bevatas. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.

Moderate
What is the effect of Bevatas on the Liver?

Bevatas may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.

Moderate
What is the effect of Bevatas on the Heart?

There may be an adverse effect on the heart after taking Bevatas. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.

Moderate

Severe Interaction of Bevatas with Other Drugs

Bevatas should not be taken with following medicines due to severe side effects it may cause to patients -

Severe

Ibuprofen

Ketorolac

Mefenamic Acid

Moderate

Digoxin

Bevatas Contraindications

If you are suffering from any of the following diseases, you should not take Bevatas unless your doctor advises you to do so -

Gastrointestinal Bleeding
Heart Disease
Diabetes
Kidney Disease
Infertility

Frequently asked Questions about Bevatas

Is this Bevatas habit forming or addictive?

Bevatas is not addictive in nature.

No
Is it safe to drive or operate heavy machinery when consuming?

You may feel sleepy or tired after taking Bevatas. So it is best to avoid driving.

Dangerous
Is it safe?

Yes, Bevatas is safe but you must consult your doctor before taking it.

Safe, but take only on Doctor's advise
Is it able to treat mental disorders?

There is no benefit of taking Bevatas for mental disorders.

No

Bevatas Interactions with Food and Alcohol

Interaction between Food and Bevatas

You can take Bevatas with food.

Safe
Interaction between Alcohol and Bevatas

It is difficult to say anything about the effect of Bevatas and alcohol. No research has been done on this yet.

Unknown

See all substitutes for Bevatas

Bevarest 400 Injection - ₹27993
Avastin Injection - ₹37373
Avastin 100 Mg Injection - ₹32250
Bevacizumab 100mg Injection - ₹32250
Bevarest 100 Injection - ₹9256
Bryxta 100 Injection 4ml - ₹11241
Bryxta 400 Injection 16 ml - ₹30358
Bevatas 100 Injection - ₹6650
Bevatas 400 Solution for infusion - ₹25243
Abevmy 100 Injection 4ml - ₹9415
Abevmy 400 Injection 16 ml - ₹24584
Bevacirel Injection - ₹27199

This medicine data has been created by -

Vikas Chauhan

B.Pharma, Pharmacy
5 Years of Experience

References

April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 224-225

KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 871

US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Avastin® (bevacizumab)

Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Avastin® (bevacizumab)

Bevatas 100 Injection